Certara Products Archives

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

CertaraSeptember 22, 2025

Announcement

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights,…

CertaraSeptember 17, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

–

CertaraSeptember 5, 2025

On-Demand Webinar

Streamline Table Creation with AI-Specialized for Regulatory Writers

Learn how AI-powered CoAuthor™ transforms table creation for regulatory and medical writers. Watch our free…

CertaraAugust 27, 2025

On-Demand Webinar

Certara Integral: The Master Data Repository Powering Efficient and Collaborative PK/PD Workflows

Charles River improved its global pharmacokinetics workflows by adopting Certara’s Integral as a central data…

CertaraAugust 27, 2025

On-Demand Webinar

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

Access our on-demand webinar to explore the key differences between eCTD 4.0 and eCTD 3.2.2.…

CertaraAugust 11, 2025

Press Release

Certara Reports Second Quarter 2025 Financial Results

RADNOR, PA— August 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraAugust 6, 2025

On-Demand Webinar

De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator

Watch the on-demand presentation covering how the DIDB® Concomitant Meds Navigator empowers clinical development teams…

CertaraAugust 5, 2025

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

CertaraJuly 31, 2025

On-Demand Webinar

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.

CertaraJuly 29, 2025

Certara Products

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

Redefining Every Stage of Investment (RESI) Seed to Exit

Streamline Table Creation with AI-Specialized for Regulatory Writers

Certara Integral: The Master Data Repository Powering Efficient and Collaborative PK/PD Workflows

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

Certara Reports Second Quarter 2025 Financial Results

De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Newsletter sign up

Quick links

Solutions

Contact